Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
218 participants
INTERVENTIONAL
2011-08-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis
NCT01022567
Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis
NCT03234296
The Value of Post-operative Antibiotic Therapy After Laparoscopic Appendectomy for Complicated Acute Appendicitis (Other Than for Generalized Peritonitis)
NCT03688295
Antibiotic Therapy Versus Appendectomy for Acute Appendicitis
NCT00135603
Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis
NCT02447224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ertapenem
Ertapenem
Ertapenem i.v,m 1g, once a day, 3 days
appendectomy
Appendectomy is compared to Ertapenem
appendectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ertapenem
Ertapenem i.v,m 1g, once a day, 3 days
appendectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first episode of suspected AA diagnosed by Andersson's score or combination with abdominal ultrasound
Exclusion Criteria
* assumption of antibiotics for different infectious disease or surgery in the last 30 days
* allergy to antibiotics established in the study protocol
* no acceptance of study protocol
* pregnancy or delivery in the last 6 months
* ASA IV or V, no Italian or English fluently speakers.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
A.O. Ospedale Papa Giovanni XXIII
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michele Pisano
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luca Ansaloni
Role: STUDY_DIRECTOR
Papa Giovanni XXIII Hospital Bergamo
Michele Pisano
Role: PRINCIPAL_INVESTIGATOR
Papa Giovanni XXIII Hospital Bergamo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
1St General Surgery Unit Papa Giovanni XXIII Hospital Bergamo
Bergamo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUDRA CT Number 2011-002977-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.